Ara
Toplam kayıt 92, listelenen: 61-70
Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3
(2016)
Background: Immunological and inflammatory mechanisms have been shown to have role in both the development and progression of diabetic nephropathy (DNP). There is need for more specific markers for inflammation as the ones ...
The Relationship Between Ghrelin Levels and the Presence of Helicobacter Pylori in the Gastric Mucosa in Uremic Patients
(2013)
OBJECTIVE: Helicobacter pylori (H. pylori) infection is an important risk factor for chronic gastritis and peptic ulcer. Ghrelin is mostly secreted by gastric mucosa. The aim of the study is to examine the relationship ...
Stimulus Duration in a Mixed Nerve Conduction Study: Decomposing Sensory Potential
(2020)
Objective: To decompose a part of the nerve action potential (NAP), mainly originating from large-myelinated sensory fibers, from mixed NAPs by using a stimulus with long duration during surface recordings.
Extracellular microRNA signature in chronic kidney disease
(2017)
MicroRNAs (miRNAs) are noncoding RNAs that regulate posttranscriptional gene expression. In this study we characterized the circulating and urinary miRNA pattern associated with reduced glomerular filtration rate, using ...
Is Pentraxin-3 a Stronger Marker of Inflammation than C-Reactive Protein in Chronic Kidney Disease?
(2014)
OBJECTIVE : Pentraxin-3 (PTX-3) is elevated in uremic patients and related with albuminuria and endothelial dysfunction. We aimed to clarify the relationship of PTX-3 with inflammatory markers (hsCRP and IL-6) in patients ...
Paroxysmal Nocturnal Hemoglobinuria and Acute Kidney Injury: A Case Report
(2013)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare cause of hemolytic anemia. The major outlines of clinical presentation comprises findings of hemolysis, venous thrombosis and findings of bone marrow failure. The ...
Antierythropoietin Antibodies in Hemodialysis Patients Treated with Recombinant Erythropoietin
(2014)
OBJECTIVE: Erythropoietin resistance is a serious problem in patients treated with recombinant erythropoietin. Antierythropoietin antibodies are considered to be one of the causes of this resistance.